1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow TNBC: new trials by email Literature Review of TNBC trials Research Report on TNBC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC HB0025 20 mg/kg plus nab-paclitaxel, HB0025 10 mg/kg plus nab-paclitaxel - TNBC | Phase 2 | Enrolling by invitation | Huabo Biopharm Co., Ltd. | 60 | 2025-08-14 | 2026-01-29 |
130-nm albumin-bound paclitaxel (1)
China (1)